OMALIZUMAB for Immunodeficiency common variable: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 12 adverse event reports in the FDA FAERS database where OMALIZUMAB was used for Immunodeficiency common variable.
Most Reported Side Effects for OMALIZUMAB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| No adverse event | 9,736 | 15.3% | 0 | 3 |
| Asthma | 9,354 | 14.7% | 208 | 4,275 |
| Urticaria | 9,231 | 14.5% | 39 | 1,723 |
| Off label use | 9,199 | 14.4% | 100 | 627 |
| Dyspnoea | 8,323 | 13.0% | 133 | 3,674 |
| Drug ineffective | 6,747 | 10.6% | 57 | 1,465 |
| Cough | 5,926 | 9.3% | 86 | 2,751 |
| Pruritus | 5,224 | 8.2% | 32 | 1,202 |
| Fatigue | 5,053 | 7.9% | 94 | 1,826 |
| Malaise | 4,820 | 7.6% | 113 | 2,032 |
| Wheezing | 4,522 | 7.1% | 78 | 2,000 |
| Headache | 4,416 | 6.9% | 47 | 1,505 |
| Pneumonia | 4,251 | 6.7% | 133 | 2,318 |
| Pain | 3,605 | 5.7% | 46 | 1,198 |
| Nasopharyngitis | 3,421 | 5.4% | 48 | 1,472 |
Other Indications for OMALIZUMAB
Asthma (24,041)
Product used for unknown indication (14,050)
Chronic spontaneous urticaria (9,063)
Idiopathic urticaria (8,366)
Urticaria (5,500)
Urticaria chronic (1,064)
Food allergy (624)
Angioedema (412)
Hypersensitivity (364)
Rhinitis allergic (305)
Other Drugs Used for Immunodeficiency common variable
HUMAN IMMUNOGLOBULIN G (17,389)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE RECOMBINANT HUMAN (1,598)
HUMAN IMMUNOGLOBULIN G\HYALURONIDASE (881)
GAMMAGARD LIQUID (81)
HIZENTRA (76)
DUPILUMAB (69)
RITUXIMAB (44)
INFLIXIMAB (28)
PREDNISOLONE (27)
HUMAN C1-ESTERASE INHIBITOR (24)